Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Nephropathy”

371 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 371 results

Testing effectiveness (Phase 2)Study completedNCT02218099
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP8232Pharmacodynamics of ASP8232+2 more
Astellas Pharma Europe B.V. 55
Testing effectiveness (Phase 2)Study completedNCT00044148
What this trial is testing

The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes

Who this might be right for
Diabetic Nephropathy
Chromaderm, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT06866158
What this trial is testing

Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease (DKD)
PT. JES Kasih Nusantara Sejahterah 80
Not applicableStudy completedNCT05631119
What this trial is testing

Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes

Who this might be right for
Diabetic Kidney DiseaseDiabetes Type 2Chronic Kidney Diseases+1 more
Sanguine Biosciences 40
Testing effectiveness (Phase 2)Study completedNCT01003236
What this trial is testing

Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Shiraz University of Medical Sciences 60
Not applicableLooking for participantsNCT07245082
What this trial is testing

Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
National Taiwan University Hospital 2,000
Post-approval studies (Phase 4)Study completedNCT01617824
What this trial is testing

Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesChronic Renal Failure
University of Padova 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06072326
What this trial is testing

DApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Who this might be right for
Type 1 Diabetes Mellitus With Diabetic Nephropathy
University Medical Center Groningen 36
Post-approval studies (Phase 4)UnknownNCT03664414
What this trial is testing

Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)

Who this might be right for
Chronic Kidney Disease stage3 and 4Type 2 Diabetes Mellitus
Maria Eugenia Galván Plata 196
Post-approval studies (Phase 4)Study completedNCT02964585
What this trial is testing

Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
George Washington University 34
Early research (Phase 1)Study completedNCT01464320
What this trial is testing

Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.

Who this might be right for
Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine
Abbott 16
Post-approval studies (Phase 4)Study completedNCT06224790
What this trial is testing

Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy

Who this might be right for
Diabetic NephropathiesType 2 Diabetes
Sidrah Lodhi 60
Testing effectiveness (Phase 2)Study completedNCT03366337
What this trial is testing

Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

Who this might be right for
IgA NephropathyCKD Associated With Type 1 DiabetesFocal Segmental Glomerulosclerosis+1 more
Biogen 103
Testing effectiveness (Phase 2)Ended earlyNCT00157508
What this trial is testing

Renal and Systemic Effects of NCX4016 in Patients With Type 2 Diabetes and Early Nephropathy

Who this might be right for
Type 2 DiabetesEarly Nephropathy
Mario Negri Institute for Pharmacological Research 13
Large-scale testing (Phase 3)Ended earlyNCT04741074
What this trial is testing

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

Who this might be right for
CKDDiabetic Kidney DiseaseType 2 Diabetes Mellitus in Obese+2 more
Geisinger Clinic 15
Testing effectiveness (Phase 2)Study completedNCT00320060
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 128
Not applicableStudy completedNCT03909269
What this trial is testing

Glycaemic Markers in Persons With Type 2 Diabetes on Haemodialysis

Who this might be right for
Diabetic Nephropathy Type 2Type2 Diabetes
Rigshospitalet, Denmark 88
Not applicableStudy completedNCT07498894
What this trial is testing

Salivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status

Who this might be right for
Diabetic Nephropathy Type 2Type 2 DiabetesPeriodontitis+2 more
Pamukkale University 126
Large-scale testing (Phase 3)Ended earlyNCT00958269
What this trial is testing

Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Phenomix 360
Early research (Phase 1)Study completedNCT00501462
What this trial is testing

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2Renal Insufficiency
GlaxoSmithKline 29
Load More Results